BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 28, 2026; 32(24): 118709
Published online Jun 28, 2026. doi: 10.3748/wjg.118709
Table 2 Risk factors for post-transcatheter arterial chemoembolization acute liver injury in patients with hepatitis B virus-related hepatocellular carcinoma
Clinical factorUnivariate logistic regression
Multivariate logistic regression
OR
95%CI
P value
OR
95%CI
P value
Sex0.7100.291-1.7310.451
Age0.9840.953-1.0150.312
Child-Pugh stage0.4090.191-0.8750.0210.3200.136-0.7010.006
BCLC0.9670.516-1.8130.917
Weight (kg)1.0070.978-1.0370.654
Height (m)0.6630.009-50.3620.852
Duration of TACE1.0040.987-1.0210.671
Number of TACE2.2451.188-4.2440.0132.1311.078-4.2590.030
Tumor diameter (mm)1.0060.998-1.0140.121
Tumor number0.7810.411-1.4840.451
PNI1.0090.999-1.020.083
CONUT0.8380.698-1.0060.058
GNRI1.0270.998-1.0580.067
TC (mmol/L)1.1250.849-1.4920.411
AFP (ng/mL)1.0001.000-1.0000.429
HBsAg (log10 IU/mL)0.9340.753-1.1580.532
HBeAg (log10 IU/mL)1.4370.743-2.780.281
HBV DNA (< 20) (IU/mL)ReferenceReferenceReferenceReferenceReferenceReference
HBV DNA (20-2000) (IU/mL)2.5661.236-5.3280.0112.5681.207-5.5730.015
HBV DNA (> 2000) (IU/mL)2.9821.288-6.9090.0112.8431.166-7.0520.022
ALT (U/L)1.0040.992-1.0170.468
AST (U/L)1.0000.994-1.0060.998
GGT (U/L)1.0000.999-1.0020.623
TBIL (μmol/L)1.0030.974-1.0330.823
ALB (g/L)1.0470.993-1.1050.09
PT (seconds)0.8120.651-1.0120.063
INR0.1520.016-1.4280.099
NLR1.0270.959-1.0990.443
WBC (× 109/L)1.0480.928-1.1840.449
NE (× 109/L)1.0520.911-1.2140.491
LYM (× 109/L)1.2040.735-1.9720.461
PLT (× 109/L)1.0000.996-1.0040.845


Write to the Help Desk